language_icon
EN
HI

Indoco Remedies Share price

INDOCO

224.9

0.63 (-0.28%)
NSE
BSE
Last updated on 15 May, 2026 | 15:48 IST
Today's High

230.00

Today's Low

223.31

52 Week Low

162.19

52 Week High

349.80

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Indoco Remedies Chart

Indoco Remedies Share Key Metrics

Volume
38656.00
Market Cap
2075.91 CR
LTQ@LTP
213@224.90
ATP
226.49
Var Margin
21.76 %
Circuit Range
180.43-270.63
Delivery %
33.82 %
Value
87.55 L
ASM/GSM
No
Market Lot
1

Summary

15 May, 2026 | 15:48 को, Indoco Remedies का शेयर प्राइस आज ₹224.9 पर है, जो दिन के लिए 0.63% की -0.28 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹223.31 और ₹230.00 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹162.19 से ₹349.80 तक रही है। ट्रेडिंग गतिविधि के मामले में, Indoco Remedies ने 38656 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹92303605 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹22649 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 213,22490 रही। यह स्टॉक ₹180.43-270.63 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹87.55 L है। दिन के लिए डिलीवरी परसेंटेज 33.82% रही। इसके अतिरिक्त, Indoco Remedies वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Indoco Remedies Fundamentals

View More
P/E Ratio

0

P/B Ratio

2.21

Div. Yield

0.09

Sector P/E

71.32

Sector P/B

3.47

Sec. Div. Yield

0.56

Indoco Remedies Resistance and Support

Pivot 228.21

Resistance

First Resistance

232.21

Second Resistance

238.89

Third Resistance

242.89

Support

First Support

221.53

Second Support

217.53

Third Support

210.85

Indoco Remedies Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

58.86%

Mutual Fund

17.54%

Insurance

0%

Foreign Institutional Investors

0.94%

Domestic Institutional Investors

0.61%

Retail

22.04%

Others

0.01%

Total Promoters
MAR '26
58.86%

Indoco Remedies Corporate Actions

DateAgenda
2026-05-07Audited Results & Final Dividend
2026-02-03Quarterly Results

Indoco Remedies News

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Indoco Remedies' Baddi Unit-I manufacturing facility has successfully received EU GMP certification from the Malta Medicines Authority. This certification confirms compliance with Good Manufacturing Practice requirements for its solid oral dosage form production.
May 14 2026 11:05:00

Indoco Remedies Limited

Indoco Remedies announced the slump sale of its Ophthalmic Division to Sunways (India) Private Limited for a cash consideration of Rs. 110 crore. This strategic move aims to enable the company to focus on its core therapeutic areas.
May 01 2026 14:05:00

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

Indoco Remedies has divested its Ophthalmic Division to Sunways (India) Private Limited for a consideration of Rs. 110 crore. This strategic move aims to enable the company to focus on its core therapeutic areas.
Apr 30 2026 19:04:00

Indoco Remedies Limited

Indoco Remedies divested its ophthalmic business division to Sunways (India) Private Limited for Rs. 110 crore. This strategic move allows Indoco to focus on its core therapeutic areas.
Apr 30 2026 19:04:00

Indoco Remedies Limited

Indoco Remedies Limited approved the transfer of its ophthalmic business in India and Africa to Sunways (India) Private Limited. This strategic move aims to sharpen Indoco's focus on core therapeutic areas with higher potential.
Apr 30 2026 19:04:00

Indoco Remedies Limited

Indoco Remedies Limited's Board approved the slump sale of its Ophthalmic Division, covering specific territories, to Sunways (India) Private Limited for Rs. 110 crores. This strategic divestment allows the company to focus on core therapeutic areas.
Apr 30 2026 18:04:00

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

Indoco Remedies' Board approved the divestment of its Ophthalmic Division in India and other territories to Sunways (India) Private Limited via a slump sale for Rs. 110 crore. This strategic move aims to sharpen the company's focus on its core therapeutic segments.
Apr 30 2026 18:04:00
Read More

About Indoco Remedies AboutThe

NSE : 11677  
BSE : 532612  
ISIN : INE873D01024  

Our HistoryWe were incorporated on August 23 1947 as Indoco Remedies Limited asa public company under the Indian Companies Act VII of 1913 and wasissued a Certificate for commencement of business on October 8 1947.In 1945 a Goan entrepreneur Mr. Govind Ramnath Kare who was in thebusiness of wholesale and retail trade of pharmaceuticals started afirm which he named Indo Continental Trading Company. The principalbusiness of this firm was to import pharmaceutical formulations fromEurope and distribute them in Western India. However in 1947 afterIndia became independent the new Government in its bid to encourageindigenous manufacturing of medicines banned import of severalformulations. Mr. G.R. Kare decided to venture into manufacturing ofpharmaceuticals. Accordingly a new Company was founded with the intentto manufacture and sell pharmaceutical formulations. Thus IndoContinental Trading Company became Indoco Remedies Limited. The Companywas incorporated with S.S. Ugrankar Mr. B K Naik Mr. A S Kamat Mr. KS Nayak Mr. V G Gaitonde Mr. N M Kamat Mr. R S Kamat and Mr. G RKare as the shareholders and S.S. Ugrankar Mr S K Ananda Rao Dr. M GCamotin Mr. E D Pai Raiturkar Mr. B K Naik Mr. VRN Rasaikar Mr. G RKare Mr. RS Kamat and Mr. V G Gaitonde as directors. Thereafter in1963 our present Chairman and Managing Director Mr Suresh G.Karetook over the management of the Company. The registered office of theCompany was located at 457 Dwarkadas Mansions Sandhurst Road BombayThis was changed to 101 Neelam Worii Seaface Road Abdul Gaffar KhanRoad Bombay 400 018 vide a board resolution dated August 15 1968which was subsequently changed to 18A Mahal Estate Mahakali CavesRoad Andheri (East) Mumbai - 400 093 vide a board resolution datedJune 1 1985 and an extra-ordinary general meeting dated May 24 1985.This was changed to the current location at 166 C.S.T. Road Santacruz(East) Mumbai - 400 098 India vide a board resolution dated December26 1999

Read More

Indoco Remedies Management

NamePosition
Suresh G KareChairman
Aditi PanandikarManaging Director
View More

Indoco Remedies FAQs

Indoco Remedies शेयर का खरीद मूल्य 224.9 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Indoco Remedies शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Indoco Remedies शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 0 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Indoco Remedies शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 2.21 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Indoco Remedies शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.47 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Indoco Remedies का मार्केट कैप 2075.91 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Indoco Remedies शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 349.80 और 162.19 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost